Polarean Imaging plc(PLLWF)
USD --+0.00%
Reward54Moderate
Risk47Moderate
📊75%Data
Revenue down 47% YoY
PLLWF
+0.0 · +0.00%
USD · PINK
Polarean Imaging plc | Healthcare
Profitless Growth
Market Cap:7.97M
ℹ️
Reward Rating
54
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
47
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on PLLWF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $1.00.

What is Polarean Imaging plc?

Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas hyperpolariser devices in Canada, the United Kingdom, and the United States.

PLLWF · Verdict

Moderate reward · moderate risk

PLLWF stands out on volatility and growth, but watch the cash flow signal.

Based on 88% data coverage

PLLWF · Verdict

What’s working & what to watch

Strengths 3

  • Volatility95/100

    Top decile vs peers

  • Growth68/100

    Rev +37.6% CAGR · earnings -15.2%

  • Valuation67/100

    Above average

Watchouts 2

  • Cash flow16/100

    -188% free-cash-flow margin

  • Profitability19/100

    -276% net margin · -81% ROE

Model-based scoring. For information only — not financial advice.

What is Polarean Imaging plc?

Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas hyperpolariser devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 7.97M.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (54)

The scoring profile indicates limited reward potential at this time, with growth and valuation offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap7.97M
P/E RatioN/A
Dividend YieldN/A
52 Week High0.021
52 Week Low0.001
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding1B
No. of Employees26
IndustryMedical Devices
ExchangePINK
Beta0.212
CurrencyUSD